| 24. | Share-based Payments |
Details of share-based payments as of December 31, 2017, are as follows:
| 11th | ||
|
Grant date |
July 27, 2017 | |
|
Grantee |
CEO, inside directors, outside directors, executives | |
|
Vesting conditions |
Service condition: 1 year Non-market performance condition: achievement of performance |
|
|
Fair value per option (in Korean won) |
￦34,400 | |
|
Total compensation costs (in Korean won) |
￦6,483 million | |
|
Estimated exercise date (exercise date) |
After July 27, 2018 |
|
|
Valuation method |
Fair value method |
Changes in the number of stock options and the weighted-average exercise price as of December 31, 2016 and 2017, are as follows:
| 2016 | ||||||||||||||||||||||||||||
| Beginning | Granted | Expired | Forfeited | Exercised1 | Ending | Number of shares exercisable |
||||||||||||||||||||||
|
9th grant |
￦ | 263,123 | ￦ | 54,913 | ￦ | 181,685 | ￦ | — | ￦ | 136,351 | ￦ | — | ￦ | — | ||||||||||||||
|
10th grant |
— | 318,506 | — | — | — | 318,506 | — | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
|
Total |
￦ | 263,123 | ￦ | 373,419 | ￦ | 181,685 | ￦ | — | ￦ | 136,351 | ￦ | 318,506 | ￦ | — | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
| 2017 | ||||||||||||||||||||||||||||
| Beginning | Granted | Expired | Forfeited | Exercised1 | Ending | Number of shares exercisable |
||||||||||||||||||||||
|
10th grant |
￦ | 318,506 | ￦ | — | ￦ | 193,094 | ￦ | — | ￦ | 125,412 | ￦ | — | ￦ | — | ||||||||||||||
|
11th grant |
— | 316,949 | — | — | — | 316,949 | — | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
|
Total |
￦ | 318,506 | ￦ | 316,949 | ￦ | 193,094 | ￦ | — | ￦ | 125,412 | ￦ | 316,949 | ￦ | — | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
| 1 | The weighted average price of ordinary shares at the time of exercise during 2017 was ￦31,797 (2016: ￦31,750). |